The contracting authority intends to purchase a variety of oncology medicines to ensure the proper functioning of hospital activities. The procurement will include specific quantities and technical specifications as outlined in the terms of reference. There are minimum and maximum quantities for the
Contract awarded. Originally published 11 months ago.
No single supplier dominates the field.
In healthcare medical, CLINICAL HOSPITAL CF NO 2 BUCHAREST has awarded 3 contracts to 3 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
The contracting authority intends to purchase a wide range of human medicines to ensure the proper functioning of hospital activities. The quantities and technical specifications are detailed in the terms of reference. There are minimum and maximum quantities for the framework agreement and subseque
The contracting authority intends to purchase a variety of laboratory reagents compatible with the Cobas Pro C 503 & E 801 integrated biochemistry and immunology analyzer. This procurement is essential for the smooth operation of hospital activities. The quantities and technical specifications are d
The contracting authority intends to purchase a variety of oncology medicines to ensure the effective operation of hospital activities. The procurement will include specific quantities and technical specifications outlined in the tender documents. There are minimum and maximum quantities for the fra
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
